Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Assessing the link between blood transfusion and recurrent intracerebral hemorrhage

EF 2025-26

Résumé
Cerebral amyloid angiopathy (CAA) is a disease whereby amyloid protein builds up in the blood vessels of the brain, making them more likely to rupture. As a result, CAA is a major cause of intracerebral hemorrhage (ICH), a type of stroke caused by bleeding inside the brain. Furthermore, individuals with CAA have a higher risk of cognitive impairment, and are more likely to experience repeated brain bleeds (recurrent ICH). Although aging is the strongest risk factor for CAA, recent research suggests that blood transfusion might also play a role. One study found that people who received blood from donors who later developed recurrent ICH had a higher risk of ICH themselves, raising the possibility that harmful amyloid proteins could be transferred through transfusions. However, more research is needed to characterize this possible link. Therefore, the goal of this study is to assess whether past blood transfusion is associated with an increased risk of recurrent ICH. Using Ontario health databases, we will identify patients who experienced recurrent ICH and determine whether they previously received a blood transfusion. We will also identify three comparison groups and examine their transfusion history: people with a single ICH event, people who had an ischemic stroke, and people who had cataract surgery. By comparing transfusion rates across these groups, we aim to assess whether recurrent ICH is linked to past blood transfusion. With one in seven hospitalized patients requiring a blood transfusion, understanding whether transfusion influences ICH risk could inform future screening practices in transfusion medicine. Because ICH also carries a high risk of death, clarifying this relationship could also impact stroke-prevention efforts.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573289
Name
Zhuang David
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Assessing the link between blood transfusion and recurrent intracerebral hemorrhage
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Administrative Health Data; Blood Transfusion; Cerebral Amyloid Angiopathy; Cerebrovascular Disease; Epidemiology; Hemorrhage; Intracerebral Hemorrhage; Neurology; Population-Based Study; Stroke
Abstract
Cerebral amyloid angiopathy (CAA) is a disease whereby amyloid protein builds up in the blood vessels of the brain, making them more likely to rupture. As a result, CAA is a major cause of intracerebral hemorrhage (ICH), a type of stroke caused by bleeding inside the brain. Furthermore, individuals with CAA have a higher risk of cognitive impairment, and are more likely to experience repeated brain bleeds (recurrent ICH). Although aging is the strongest risk factor for CAA, recent research suggests that blood transfusion might also play a role. One study found that people who received blood from donors who later developed recurrent ICH had a higher risk of ICH themselves, raising the possibility that harmful amyloid proteins could be transferred through transfusions. However, more research is needed to characterize this possible link. Therefore, the goal of this study is to assess whether past blood transfusion is associated with an increased risk of recurrent ICH. Using Ontario health databases, we will identify patients who experienced recurrent ICH and determine whether they previously received a blood transfusion. We will also identify three comparison groups and examine their transfusion history: people with a single ICH event, people who had an ischemic stroke, and people who had cataract surgery. By comparing transfusion rates across these groups, we aim to assess whether recurrent ICH is linked to past blood transfusion. With one in seven hospitalized patients requiring a blood transfusion, understanding whether transfusion influences ICH risk could inform future screening practices in transfusion medicine. Because ICH also carries a high risk of death, clarifying this relationship could also impact stroke-prevention efforts.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhuang, David
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~